The power of MEMS

Micro-Electro-Mechanical Systems (MEMS) are key components of smart biomedical systems, enabling miniaturised devices with diagnostic, prognostic and therapeutic functionalities.

Although these systems are poised to revolutionize medical diagnostics and treatment approaches, the slow progress in the development of biocompatible actuator materials used in these devices is still hindering this industry, preventing a host of new biomedical devices to enter the mainstream market.

A new generation of smart materials

BioWings’ main goal is to study, understand and implement a new class of smart actuating materials, based on highly defective cerium oxides, which recently displayed unique properties:

• non-toxicity and environmentally friendliness, unlike the current lead-based actuators;
• exceptionally high and still uncapped electrostrictive response under moderate electric fields, enabling low power consumption devices;
• full compatibility with silicon-based technologies and many other substrates, including metals and polymers.

The project will bring the technology to TRL4, preparing the ground for the industrialisation of a new class of “biomedical MEMS” with increasing geometrical and functional complexity, suitable for a large variety of implantable and/or diagnostic applications.

Moreover, the results will be demonstrated in real biomedical applications: ultrasonic generation (MHz) in microprobes and blood cell sorting for bacteria separation and haematocrit level (HCT) estimation.